J. Bashford, J. Norwood, and S. Chapman, Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database, BMJ, vol.317, issue.7156, pp.452-458, 1998.
DOI : 10.1136/bmj.317.7156.452

M. Sturkenboom, T. Burke, J. Dieleman, M. Tangelder, F. Lee et al., Underutilization of preventive strategies in patients receiving NSAIDs, Rheumatology, vol.42, issue.90003, pp.23-31, 2003.
DOI : 10.1093/rheumatology/keg495

G. Thiefin, C complications gastro-intestinales des anti-inflammatoires non stéroïdiens et de l'aspirine à faible dose, Gastroenterol Clin Biol, vol.27, pp.498-510, 2003.

. Conférence-de-consensus, Société nationale française de gastro-entérologie . Reflux gastro-oesophagien de l'adulte: " diagnostic et traitement " . Tours: SNFG;1999, Gastroenterol Clin Bio, vol.23, p.1, 1999.

I. Barthelme, Prescrire hors AMM, les raisons, les risques, Concours Med, vol.127, issue.06, pp.349-52, 2005.

E. Larkai, J. Smith, M. Lidsky, and D. Graham, Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use, Am J Gastroenterol, vol.82, pp.1153-1161, 1987.

C. Armstrong and A. Blower, Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration., Gut, vol.28, issue.5, pp.527-559, 1987.
DOI : 10.1136/gut.28.5.527

G. Singh, D. Ramey, D. Morfeld, H. Shi, H. Hatoum et al., Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study, Archives of Internal Medicine, vol.156, issue.14, pp.1530-1536, 1996.
DOI : 10.1001/archinte.156.14.1530

R. Shorr, W. Ray, J. Daugherty, and M. Griffin, Concurrent Use of Nonsteroidal Anti-inflammatory Drugs and Oral Anticoagulants Places Elderly Persons at High Risk for Hemorrhagic Peptic Ulcer Disease, Archives of Internal Medicine, vol.153, issue.14, pp.1665-70, 1993.
DOI : 10.1001/archinte.1993.00410140047006

J. Huang, S. Sridhar, and R. Hunt, Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis, The Lancet, vol.359, issue.9300, pp.14-22, 2002.
DOI : 10.1016/S0140-6736(02)07273-2

P. Bytzer, Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients, American Journal of Gastroenterology, vol.334, issue.3s, pp.31-39, 2003.
DOI : 10.1016/S0002-9270(03)00013-3

M. Naunton, G. Peterson, and M. Bleasel, Overuse of proton pump inhibitors, J Clin Pharm Ther, vol.25, pp.333-373, 2000.

N. Talley, M. Moore, A. Sprogis, and P. Katelaris, Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care, Med J Aust, vol.177, pp.423-430, 2002.

P. Maton, R. Orlando, and B. Joelsson, Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease-a prospective, controlled trial, Alimentary Pharmacology and Therapeutics, vol.40, issue.6, pp.819-845, 1999.
DOI : 10.1046/j.1365-2168.1998.00834.x

R. Jian, Z. Hassani, E. Kebir, S. Barthelemy, and P. , Management of gastro-esophageal reflux disease in primary care. Results from an observational study of 2 474 patients, Gastroent??rologie Clinique et Biologique, vol.31, issue.1, pp.72-79, 2007.
DOI : 10.1016/S0399-8320(07)89329-8